跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 333,250 条关于
“5-HT₂A”
全部
333,250
临床试验
279,947
药物
8,049
机构
4,520
资讯
40,734
去年
Enveric Biosciences Publishes Breakthrough Research on Microbial Bioproduction of Neuropsychiatric Compounds
6个月前
Enveric Biosciences Secures Patent Victory as AbbVie Withdraws Challenge Following $1.2 Billion Gilgamesh Acquisition
9个月前
Enveric Biosciences Secures Fourth Patent for Non-Hallucinogenic Neuroplastogenic Drug Candidates
9个月前
Enveric Biosciences Raises $3.1 Million Through Warrant Exercise to Advance Neuroplastogenic Therapeutics
去年
AbbVie Acquires Gilgamesh's Breakthrough Depression Treatment Bretisilocin for $1.2 Billion
去年
Halia Therapeutics Doses First Healthy Volunteer with Oral LRRK2 Inhibitor HT-4253 for Alzheimer's
去年
Hoth Therapeutics Strengthens Intellectual Property Portfolio with New Patent Filings for HT-001 and HT-KIT
去年
Hoth Therapeutics Receives US Patent for HT-ALZ, a Novel Alzheimer's Treatment
去年
Hoth Therapeutics' HT-001 Demonstrates 100% Success in Phase 2a Trial for Cancer Treatment Skin Toxicities
2年前
TAK-906: Peripheral D2/D3 Antagonist Under Development for Gastroparesis
第 1 页,共 4074 页
上一页
下一页